NCT00944632 Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00932074 A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD) Status COMPLETED Phase PHASE1/PHASE2
NCT00931411 Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis Status TERMINATED Phase NA
NCT00927212 Topical Application of AS101 for the Treatment of Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT00925730 Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion Status COMPLETED Phase PHASE4
NCT00919763 Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00914186 Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC) Status COMPLETED Phase PHASE2
NCT00903357 The Effectiveness of Montelukast on Atopic Dermatitis in Koreans Status COMPLETED Phase NA
NCT00891709 LEO 29102 Single and Multiple Dose Study by Dermal Application Status COMPLETED Phase PHASE1
NCT00886587 To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children Status COMPLETED Phase NA
NCT00883311 A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00882245 Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00879944 Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index Status COMPLETED Phase N/A
NCT00871208 Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy Status WITHDRAWN Phase PHASE4
NCT00863005 Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study Status COMPLETED Phase PHASE1/PHASE2